Top

Published in:

01-02-2019 | Hypertension | Implementation to Increase Blood Pressure Control: What Works? (Jeffrey Brettler and Kristi Reynolds, Section Editors)

Implementing Home Blood Pressure Monitoring into Clinical Practice

Authors: Nadia Liyanage-Don, Deborah Fung, Erica Phillips, Ian M. Kronish

Published in: Current Hypertension Reports | Issue 2/2019

Abstract

Purpose of Review

To review data supporting the use of home blood pressure monitoring (HBPM) and provide practical guidance to clinicians wishing to incorporate HBPM into their practice.

Recent Findings

HBPM more accurately reflects the risk of cardiovascular events than office blood pressure measurement. In addition, there is high-quality evidence that HBPM combined with clinical support improves blood pressure control. Therefore, HBPM is increasingly recommended by guidelines to confirm the diagnosis of hypertension and evaluate the efficacy of blood pressure-lowering medications. Nevertheless, HBPM use remains low due to barriers from the patient, clinician, and healthcare system level. Understanding these barriers is crucial for developing strategies to effectively implement HBPM into routine clinical practice.

Summary

HBPM is a valuable adjunct to office blood pressure measurement for diagnosing hypertension and guiding antihypertensive therapy. Following recommended best practices can facilitate the successful implementation of HBPM and impact how hypertension is managed in the primary care setting.

Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, et al. Screening for high blood pressure in adults: a systematic evidence review for the US Preventive Services Task Force. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Rockville (MD)2014.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.CrossRefPubMed

Bauer F, Seibert FS, Rohn B, Bauer KAR, Rolshoven E, Babel N, et al. Attended versus unattended blood pressure measurement in a real life setting. Hypertension. 2018;71(2):243–9.PubMedCrossRef

Sharman JE, Howes FS, Head GA, McGrath BP, Stowasser M, Schlaich M, et al. Home blood pressure monitoring: Australian Expert Consensus Statement. J Hypertens. 2015;33(9):1721–8.PubMedPubMedCentralCrossRef

Band R, Bradbury K, Morton K, May C, Michie S, Mair FS, et al. Intervention planning for a digital intervention for self-management of hypertension: a theory-, evidence- and person-based approach. Implement Sci. 2017;12(1):25.PubMedPubMedCentralCrossRef

Siu AL. Force USPST. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778–86.PubMedCrossRef

Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–83.PubMedCrossRefPubMedCentral

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.PubMedPubMedCentralCrossRef

Centers for Disease C, Prevention. CDC Grand Rounds: the million hearts initiative. MMWR Morb Mortal Wkly Rep. 2012;61(50):1017–21.

10.

Michael Rakotz M. Improving blood pressure control: Measure, Act and Partner (M.A.P.) to help patients control blood pressure and ultimately prevent heart disease. 2015 [Available from: https://edhub.ama-assn.org/steps-forward/module/2702688. Accessed 20 Jan 2019

11.

•• Reboussin DM, Allen NB, Griswold ME, Guallar E, Hong Y, Lackland DT, et al. Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e595–616 This systematic review and meta-analysis provides an estimate of the blood pressure and adverse cardiovascular event-lowering effect of self-measured blood pressure monitoring versus office blood pressure measurement.PubMedCrossRef

12.

Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension. 2009;53(3):480–6.PubMedCrossRef

13.

Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043–50.PubMedCrossRef

14.

Park S, Buranakitjaroen P, Chen CH, Chia YC, Divinagracia R, Hoshide S, et al. Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network. J Hum Hypertens. 2018;32(4):249–58.PubMedCrossRef

15.

Cohen JB, Cohen DL. Integrating out-of-office blood pressure in the diagnosis and management of hypertension. Curr Cardiol Rep. 2016;18(11):112.PubMedPubMedCentralCrossRef

16.

Birkett NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens. 1997;15(3):237–44.PubMedCrossRef

17.

Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16(7):971–5.PubMedCrossRef

18.

Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64(5):989–96.PubMedCrossRef

19.

Kario K, Saito I, Kushiro T, Teramukai S, Tomono Y, Okuda Y, et al. Morning home blood pressure is a strong predictor of coronary artery disease: the HONEST Study. J Am Coll Cardiol. 2016;67(13):1519–27.PubMedCrossRef

20.

Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan Morning Surge-Home Blood Pressure Study. Hypertension. 2016;68(1):54–61.PubMedCrossRef

21.

Niiranen TJ, Hanninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010;55(6):1346–51.PubMedCrossRef

22.

Tsunoda S, Kawano Y, Horio T, Okuda N, Takishita S. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res. 2002;25(2):167–73.PubMedCrossRef

23.

Mule G, Caimi G, Cottone S, Nardi E, Andronico G, Piazza G, et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk. 2002;9(2):123–9.PubMedCrossRef

24.

Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens. 2008;26(10):1919–27.PubMedCrossRef

25.

Tachibana R, Tabara Y, Kondo I, Miki T, Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res. 2004;27(9):633–9.PubMedCrossRef

26.

Matsumoto A, Satoh M, Kikuya M, Ohkubo T, Hirano M, Inoue R, et al. Day-to-day variability in home blood pressure is associated with cognitive decline: the Ohasama Study. Hypertension. 2014;63(6):1333–8.PubMedCrossRef

27.

Imai Y, Ohkubo T, Sakuma M, Tsuji II, Satoh H, Nagai K, et al. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. Blood Press Monit. 1996;1(3):251–4.PubMed

28.

Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777–83.PubMedCrossRef

29.

Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens. 2012;30(3):449–56.PubMedCrossRef

30.

Fuchs SC, Mello RG, Fuchs FC. Home blood pressure monitoring is better predictor of cardiovascular disease and target organ damage than office blood pressure: a systematic review and meta-analysis. Curr Cardiol Rep. 2013;15(11):413.PubMedCrossRef

31.

Noguchi Y, Asayama K, Staessen JA, Inaba M, Ohkubo T, Hosaka M, et al. Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetes. J Hypertens. 2013;31(8):1593–602.PubMedCrossRef

32.

Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ. 2013;185(11):949–57.PubMedPubMedCentralCrossRef

33.

Lv J, Neal B, Ehteshami P, Ninomiya T, Woodward M, Rodgers A, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med. 2012;9(8):e1001293.PubMedPubMedCentralCrossRef

34.

Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels—overview and meta-analyses of randomized trials. J Hypertens. 2014;32(12):2296–304.PubMedCrossRef

35.

Stergiou GS, Kario K, Kollias A, McManus RJ, Ohkubo T, Parati G, et al. Home blood pressure monitoring in the 21st century. J Clin Hypertens (Greenwich). 2018;20(7):1116–21.CrossRef

36.

Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1–9.PubMedCrossRef

37.

Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24(12):779–85.PubMedCrossRef

38.

Krause T, Lovibond K, Caulfield M, McCormack T, Williams B, Guideline Development G. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.PubMedCrossRef

39.

Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37(4):253–390.PubMedCrossRef

40.

Cloutier L, Daskalopoulou SS, Padwal RS, Lamarre-Cliche M, Bolli P, McLean D, et al. A new algorithm for the diagnosis of hypertension in Canada. Can J Cardiol. 2015;31(5):620–30.PubMedCrossRef

41.

•• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324 This article summarizes the most up-to-date US hypertension practice guidelines. The guidelines include a recommended clinical protocol for conducting home blood pressure monitoring, as well as thresholds for diagnosing sustained hypertension, white coat hypertension, and masked hypertension.PubMedCrossRef

42.

Fletcher BR, Hinton L, Bray EP, Hayen A, Hobbs FR, Mant J, et al. Self-monitoring blood pressure in patients with hypertension: an internet-based survey of UK GPs. Br J Gen Pract. 2016;66(652):e831–e7.PubMedPubMedCentralCrossRef

43.

Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, et al. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens. 2002;15(2 Pt 1):101–4.PubMedCrossRef

44.

Warren RE, Marshall T, Padfield PL, Chrubasik S. Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements. Br J Gen Pract. 2010;60(578):675–80.PubMedPubMedCentralCrossRef

45.

Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens. 2000;13(6 Pt 1):632–9.PubMedCrossRef

46.

Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, et al. Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens. 2006;24(1):169–75.PubMedCrossRef

47.

Fletcher BR, Hinton L, Hartmann-Boyce J, Roberts NW, Bobrovitz N, McManus RJ. Self-monitoring blood pressure in hypertension, patient and provider perspectives: a systematic review and thematic synthesis. Patient Educ Couns. 2016;99(2):210–9.PubMedCrossRef

48.

Jones MI, Greenfield SM, Bray EP, Baral-Grant S, Hobbs FD, Holder R, et al. Patients’ experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. Br J Gen Pract. 2012;62(595):e135–42.PubMedCrossRef

49.

Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011;24(2):123–34.PubMedCrossRef

50.

Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57(1):29–38.PubMedCrossRef

51.

Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K, et al. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60(4):921–8.PubMedCrossRef

52.

Ishikawa J, Shimizu M, Sugiyama Edison E, Yano Y, Hoshide S, Eguchi K, et al. Assessment of the reductions in night-time blood pressure and dipping induced by antihypertensive medication using a home blood pressure monitor. J Hypertens. 2014;32(1):82–9.PubMed

53.

Ushio H, Ishigami T, Araki N, Minegishi S, Tamura K, Okano Y, et al. Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure. Clin Exp Nephrol. 2009;13(5):480–5.PubMedCrossRef

54.

Stergiou GS, Triantafyllidou E, Cholidou K, Kollias A, Destounis A, Nasothimiou EG, et al. Asleep home blood pressure monitoring in obstructive sleep apnea: a pilot study. Blood Press Monit. 2013;18(1):21–6.PubMedCrossRef

55.

Task Force CPS. Self-measured blood pressure monitoring improves outcomes: recommendation of the Community Preventive Services Task Force. Am J Prev Med. 2017;53(3):e115–e8.PubMedCrossRef

56.

Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159(3):185–94.PubMedCrossRef

57.

•• Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389 This study conducts a systematic review and meta-analysis of the effect of blood pressure self-monitoring with and without clinician support on blood pressure control.PubMedPubMedCentralCrossRef

58.

McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163–72.PubMedCrossRef

59.

Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FD, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21(12):1517–30.PubMedCrossRef

60.

McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808.PubMedCrossRef

61.

• McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–59 This article describes the results of a pragmatic randomized clinical trial that compares self-monitored blood pressure with and without telemonitoring versus office blood pressure management of hypertension. The authors found that self-monitored blood pressure with or without telemonitoring was superior to office blood pressure management, resulting in a 4.7-mmHg and 3.5-mmHg reduction in blood pressure, respectively.PubMedPubMedCentralCrossRef

62.

Salazar MR, Espeche WG, Stavile RN, Balbin E, Leiva Sisnieguez BC, Leiva Sisnieguez CE, et al. Could self-measured office blood pressure be a hypertension screening tool for limited-resources settings? J Hum Hypertens. 2018;32(6):415–22.PubMedCrossRef

63.

Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens. 2005;18(6):772–8.PubMedCrossRef

64.

Furusawa EA, Filho UD, Junior DM, Koch VH. Home and ambulatory blood pressure to identify white coat and masked hypertension in the pediatric patient. Am J Hypertens. 2011;24(8):893–7.PubMedCrossRef

65.

Nasothimiou EG, Tzamouranis D, Rarra V, Roussias LG, Stergiou GS. Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension. Hypertens Res. 2012;35(7):750–5.PubMedCrossRef

66.

Zhang L, Li Y, Wei FF, Thijs L, Kang YY, Wang S, et al. Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement. Hypertension. 2015;65(6):1258–65.PubMedCrossRef

67.

Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47(5):846–53.PubMedCrossRef

68.

Satoh M, Asayama K, Kikuya M, Inoue R, Metoki H, Hosaka M, et al. Long-term stroke risk due to partial white-coat or masked hypertension based on home and ambulatory blood pressure measurements: the Ohasama Study. Hypertension. 2016;67(1):48–55.PubMedCrossRef

69.

Anstey DE, Muntner P, Bello NA, Pugliese DN, Yano Y, Kronish IM, et al. Diagnosing masked hypertension using ambulatory blood pressure monitoring, home blood pressure monitoring, or both? Hypertension. 2018;72(5):1200–7.PubMedCrossRef

70.

Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163(9):691–700.PubMedPubMedCentralCrossRef

71.

Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, et al. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) collaboration statement. Hypertension. 2018;71(3):368–74.PubMedCrossRef

72.

• Bello NA, Woolley JJ, Cleary KL, Falzon L, Alpert BS, Oparil S, et al. Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies. Hypertension. 2018;71(2):326–35 This article informs home blood pressure monitoring protocols by providing empiric data on how increasing the frequency of home blood pressure readings affects the reliability of home blood pressure estimates. Among patients without severely elevated blood pressure, as few as 3 days of HBPM readings may be sufficient to obtain reliable blood pressure estimates.PubMedCrossRef

73.

Eguchi K, Kuruvilla S, Ishikawa J, Schwartz JE, Pickering TG. A novel and simple protocol for the validation of home blood pressure monitors in clinical practice. Blood Press Monit. 2012;17(5):210–3.PubMedCrossRef

74.

O’Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322(7285):531–6.PubMedPubMedCentralCrossRef

75.

Handler J. The importance of accurate blood pressure measurement. Perm J. 2009;13(3):51–4.PubMedPubMedCentralCrossRef

76.

Parati G, Dolan E, McManus RJ, Omboni S. Home blood pressure telemonitoring in the 21st century. J Clin Hypertens (Greenwich). 2018;20(7):1128–32.CrossRefPubMedCentral

77.

Bello NA, Schwartz JE, Kronish IM, Oparil S, Anstey DE, Wei Y, et al. Number of measurements needed to obtain a reliable estimate of home blood pressure: results from the improving the detection of hypertension study. J Am Heart Assoc. 2018;7(20):e008658.PubMedCrossRefPubMedCentral

78.

Wood PW, Boulanger P, Padwal RS. Home blood pressure telemonitoring: rationale for use, required elements, and barriers to implementation in Canada. Can J Cardiol. 2017;33(5):619–25.PubMedCrossRef

79.

Omboni S, Caserini M, Coronetti C. Telemedicine and M-health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev. 2016;23(3):187–96.PubMedCrossRef

80.

Jones MI, Greenfield SM, Bray EP, Hobbs FR, Holder R, Little P, et al. Patient self-monitoring of blood pressure and self-titration of medication in primary care: the TASMINH2 trial qualitative study of health professionals’ experiences. Br J Gen Pract. 2013;63(611):e378–85.PubMedPubMedCentralCrossRef

81.

Morrissey EC, Glynn LG, Casey M, Walsh JC, Molloy GJ. New self-management technologies for the treatment of hypertension: general practitioners’ perspectives. Fam Pract. 2018;35(3):318–22.PubMedCrossRef

82.

Park JS, Rhee MY, Namgung J, Lee SY, Cho DK, Choi TY, et al. Comparison of optimal diagnostic thresholds of hypertension with home blood pressure monitoring and 24-hour ambulatory blood pressure monitoring. Am J Hypertens. 2017;30(12):1170–6.PubMedCrossRef

83.

Muntner P, Carey RM, Jamerson K, Wright JT Jr, Whelton PK. Rationale for ambulatory and home blood pressure monitoring thresholds in the 2017 American College of Cardiology/American Heart Association Guideline. Hypertension. 2019;73(1):33–8.PubMedCrossRef

84.

Hanninen MR, Niiranen TJ, Puukka PJ, Johansson J, Jula AM. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home study. J Hypertens. 2012;30(4):705–12.PubMedCrossRef

85.

Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63(4):675–82.PubMedCrossRef

86.

Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol. 2015;66(20):2159–69.PubMedPubMedCentralCrossRef

87.

Franklin SS, Thijs L, Hansen TW, O’Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62(6):982–7.PubMedCrossRef

88.

Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378(16):1509–20.PubMedCrossRef

89.

Diaz KM, Veerabhadrappa P, Brown MD, Whited MC, Dubbert PM, Hickson DA. Prevalence, determinants, and clinical significance of masked hypertension in a population-based sample of African Americans: the Jackson Heart Study. Am J Hypertens. 2015;28(7):900–8.PubMedCrossRef

90.

Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, et al. Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016;11(4):642–52.PubMedPubMedCentralCrossRef

91.

Ostchega YZG, Kit BK, Nwankwo T. Factors associated with home blood pressure monitoring among US adults: National Health and Nutrition Examination Survey, 2011-2014. Am J Hypertens. 2017;30(11):1126–32.PubMedCrossRef

92.

Dymek JSA, Polak W, Gołda A. Assessment of knowledge and skills of patients with hypertension related to self-measurement of blood pressure (SBPM). Arterial Hypertension. 2015;1(1):39–44.CrossRef

93.

Mondal S, Mondal H, Dutta R, Pal A, Acharya SS, Baidya C. Competency in home blood pressure monitoring and effect of training program on competency 2018.

94.

Akpolat TAM, Sengul S, Derici U, Ulusoy S, Erturk S, Erdem Y. Home sphygmomanometers can help in the control of blood pressure: a nationwide field survey. Hypertens Res. 2018;41(6):460–8.PubMedCrossRefPubMedCentral

95.

Milot JP, Birnbaum L, Larochelle P, Wistaff R, Laskine M, Van Nguyen P, et al. Unreliability of home blood pressure measurement and the effect of a patient-oriented intervention. Can J Cardiol. 2015;31(5):658–63.PubMedCrossRef

96.

Logan AG, Dunai A, McIsaac WJ, Irvine MJ, Tisler A. Attitudes of primary care physicians and their patients about home blood pressure monitoring in Ontario. J Hypertens. 2008;26(3):446–52.PubMedCrossRef

97.

Doane J, Buu J, Penrod MJ, Bischoff M, Conroy MB, Stults B. Measuring and managing blood pressure in a primary care setting: a pragmatic implementation study. J Am Board Fam Med. 2018;31(3):375–88.PubMedCrossRef

98.

Carrera PM, Lambooij MS. Implementation of out-of-office blood pressure monitoring in the Netherlands: from clinical guidelines to patients’ adoption of innovation. Medicine (Baltimore). 2015;94(43):e1813.CrossRef

99.

• Carter EJ, Moise N, Alcantara C, Sullivan AM, Kronish IM. Patient barriers and facilitators to ambulatory and home blood pressure monitoring: a qualitative study. Am J Hypertens. 2018;31(8):919–27 This study highlights barriers and facilitators to home blood pressure monitoring from the perspective of patients recruited from underserved areas of New York City.PubMedCrossRefPubMedCentral

100.

Wood S, Greenfield SM, Sayeed Haque M, Martin U, Gill PS, Mant J, et al. Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary care. Br J Gen Pract. 2016;66(649):e577–86.PubMedPubMedCentralCrossRef

101.

Tirabassi J, Fang J, Ayala C. Attitudes of primary care providers and recommendations of home blood pressure monitoring—DocStyles, 2010. J Clin Hypertens (Greenwich). 2013;15(4):224–9.CrossRef

102.

Chalmers J, Arima H, Harrap S, Touyz RM, Park JB. Global survey of current practice in management of hypertension as reported by societies affiliated with the International Society of Hypertension. J Hypertens. 2013;31(5):1043–8.PubMedCrossRef

103.

Martín-Rioboó E, Pérula de Torres LA, Banegas JR, Lobos-Bejarano JM, Brotons Cuixart C, García Criado EI, et al. Knowledge, availability, and use of ambulatory and home blood pressure monitoring in primary care in Spain: the MAMPA study. J Hypertens. 2018;36(5):1051–8.PubMedCrossRef

104.

• Kronish IM, Kent S, Moise N, Shimbo D, Safford MM, Kynerd RE, et al. Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States. J Am Soc Hypertens. 2017;11(9):573–80 This study describes key barriers to home blood pressure monitoring from the perspective of primary care physicians practicing in two regions of the USA.PubMedPubMedCentralCrossRef

105.

Robins LS, Jackson JE, Green BB, Korngiebel D, Force RW, Baldwin LM. Barriers and facilitators to evidence-based blood pressure control in community practice. J Am Board Fam Med. 2013;26(5):539–57.PubMedCrossRef

106.

Bradbury K, Morton K, Band R, May C, McManus R, Little P, et al. Understanding how primary care practitioners perceive an online intervention for the management of hypertension. BMC Med Inform Decis Mak. 2017;17(1):5.PubMedPubMedCentralCrossRef

107.

Arrieta A, Woods JR, Qiao N, Jay SJ. Cost-benefit analysis of home blood pressure monitoring in hypertension diagnosis and treatment: an insurer perspective. Hypertension. 2014;64(4):891–6.PubMedCrossRef

108.

Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378(9798):1219–30.PubMedCrossRef

109.

Soghikian K, Casper SM, Fireman BH, Hunkeler EM, Hurley LB, Tekawa IS, et al. Home blood pressure monitoring. Effect on use of medical services and medical care costs. Med Care. 1992;30(9):855–65.PubMedCrossRef

110.

Reed SD, Li Y, Oddone EZ, Neary AM, Orr MM, Grubber JM, et al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens. 2010;23(2):142–8.PubMedCrossRef

111.

Cacciolati C, Tzourio C, Dufouil C, Alperovitch A, Hanon O. Feasibility of home blood pressure measurement in elderly individuals: cross-sectional analysis of a population-based sample. Am J Hypertens. 2012;25(12):1279–85.PubMed

112.

Mills KT, Obst KM, Shen W, Molina S, Zhang HJ, He H, et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis. Ann Intern Med. 2018;168(2):110–20.PubMedCrossRef

113.

Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens. 2015;9(2):130–6.PubMedCrossRef

114.

Hwang KO, Thomas EJ, Petersen LA. Use of home blood pressure results for assessing the quality of care for hypertension. JAMA. 2018;320(17):1753–4.PubMedCrossRef

115.

Liao JM, Navathe AS, Press MJ. Medicare’s approach to paying for services that promote coordinated care. JAMA. 2018.

Title: Implementing Home Blood Pressure Monitoring into Clinical Practice
Authors: Nadia Liyanage-Don
Deborah Fung
Erica Phillips
Ian M. Kronish
Publication date: 01-02-2019
Publisher: Springer US
Keywords: Hypertension
Hypertension
Published in: Current Hypertension Reports / Issue 2/2019
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-019-0916-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2019

Weight Loss Medications in the Treatment of Obesity and Hypertension

Dietary Fat and Blood Pressure

Incorporation of Novel Vascular Measures into Clinical Management: Recent Insights from the Framingham Heart Study

Personalized Medicine and the Treatment of Hypertension

Real-World Strategies to Treat Hypertension Associated with Pediatric Obesity

Four-Limb Blood Pressure Measurement with an Oscillometric Device: a Tool for Diagnosing Peripheral Vascular Disease

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials